Edwards Lifesciences Corp (EW)

EW (NYSE:Health Services)
$129.38
neg -0.76
-0.58%
Today's Range: 128.29 - 130.45 | EW Avg Daily Volume: 891,400
Last Update: 01/27/15 - 4:01 PM EST
Volume: 545,612
YTD Performance: 2.17%
Open: $129.39
Previous Close: $130.14
52 Week Range: $63.04 - $137.19
Oustanding Shares: 106,974,215
Market Cap: 13,867,067,490
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 10 10 11
Moderate Buy 0 0 0 0
Hold 8 7 7 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.94 1.82 1.82 1.71
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 18.03
Price Earnings Comparisons:
EW Sector Avg. S&P 500
18.03 18.00 25.92
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.46% 89.13% 66.27%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.41 0.12
Net Income 33.60 0.80 0.21
EPS 38.90 0.83 0.22
Earnings for EW:
EBITDA 0.52B
Revenue 2.05B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.94 $0.94 $3.38 $4.01
Number of Analysts 11 9 12 12
High Estimate $1.00 $0.98 $3.44 $4.07
Low Estimate $0.91 $0.89 $3.35 $3.96
Prior Year $0.91 $0.76 $3.13 $3.38
Growth Rate (Year over Year) 3.50% 24.12% 7.91% 18.87%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

bullishEdwards Lifesciences numbers increased at BMO

Dec 9, 2014 | 7:43 AM EST

EW estimates were raised through 2016, BMO Capital said. Management boosted guidance. Market Perform rating and new $135 price target. 

bullishEdwards Lifesciences estimates, price target raised at Barclays

Dec 9, 2014 | 7:32 AM EST

EW price target raised to $100 from $92, said Barclays. Following analyst day, market growth and EPS estimates raised. 

bullishEdwards Lifesciences price target raised at Leerink

Dec 1, 2014 | 8:08 AM EST

EW price target raised to $142 from $125, said Leerink. Model updated to reflect modest changes in Transcatheter Aortic Valve Replacement sales, while Europe growth figures reduced conservatively. Rating remains Outperform.

By

Jim Cramer

 | Nov 24, 2014 | 4:12 PM EST

This market provides a slew of reasons to buy right now.

By

Jim Cramer

 | Nov 17, 2014 | 4:33 AM EST

There's a powerful collection of "what's working."

bullishEdwards Lifesciences price target raised at Barclays

Oct 24, 2014 | 7:37 AM EDT

EW price target raised to $92 from $73, said Barclays. 3Q results above consensus on top and bottom line, solidifying an overwhelmingly positive quarter as company continues to take share. Remain equal weight because future compeitition and pricing pressure is likely. 

bullishEdwards Lifesciences numbers boosted at JMP

Aug 21, 2014 | 7:22 AM EDT

Shares of EW now seen reaching $120, according to JMP Securities. Estimates also upped, as growth in the global TAVI market may accelerate. Outperform rating.

By

Jim Cramer

 | Aug 4, 2014 | 11:45 AM EDT

These quality names look appealing on the basis of 30-week moving average.

On day's high and +$1.24 on the day.

this stock is unnaturally strong --domestic with yield--but there is no option activity so...
Market recovering slightly from deep early losses, but indices still lower than where they...
S&P futures bounced inside our zone @ 2020.30-2011.10. The S&P futures are not sho...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.